SEC31A
Basic information
Region (hg38): 4:82818509-82901166
Previous symbols: [ "SEC31L1" ]
Links
Phenotypes
GenCC
Source:
- neurodevelopmental disorder with spastic quadriplegia, optic atrophy, seizures, and structural brain anomalies (Limited), mode of inheritance: AR
- neurodevelopmental disorder with spastic quadriplegia, optic atrophy, seizures, and structural brain anomalies (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Halperin-Birk syndrome | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic | 30464055 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SEC31A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | |||||
missense | 60 | 66 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 2 | 1 | 3 | |||
non coding | 3 | |||||
Total | 0 | 0 | 61 | 11 | 9 |
Variants in SEC31A
This is a list of pathogenic ClinVar variants found in the SEC31A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-82819090-T-C | not specified | Uncertain significance (Feb 28, 2023) | ||
4-82819214-T-C | not specified | Uncertain significance (Sep 02, 2024) | ||
4-82819235-T-C | not specified | Uncertain significance (Dec 01, 2023) | ||
4-82824576-G-C | not specified | Uncertain significance (Nov 06, 2023) | ||
4-82824590-G-C | not specified | Uncertain significance (Nov 15, 2021) | ||
4-82824637-T-G | not specified | Uncertain significance (Jun 29, 2023) | ||
4-82824655-G-A | not specified | Uncertain significance (Jun 30, 2022) | ||
4-82824658-G-A | not specified | Uncertain significance (Sep 16, 2021) | ||
4-82827405-T-G | not specified | Uncertain significance (Jul 25, 2023) | ||
4-82827414-G-A | Likely benign (Jul 26, 2018) | |||
4-82827464-C-T | Likely benign (May 01, 2024) | |||
4-82827532-G-A | not specified | Uncertain significance (Jan 30, 2024) | ||
4-82827568-G-A | Benign (Dec 31, 2019) | |||
4-82827568-G-C | not specified | Uncertain significance (Jul 09, 2024) | ||
4-82827632-T-C | not specified | Uncertain significance (Dec 09, 2023) | ||
4-82829002-T-C | not specified | Uncertain significance (Sep 08, 2024) | ||
4-82842139-C-A | SEC31A-related disorder | Likely benign (Feb 01, 2022) | ||
4-82842191-T-C | not specified | Uncertain significance (Jul 14, 2021) | ||
4-82842197-G-T | not specified | Uncertain significance (Nov 12, 2024) | ||
4-82842199-G-C | not specified | Uncertain significance (Nov 10, 2022) | ||
4-82842234-T-C | Likely benign (May 01, 2022) | |||
4-82842240-G-A | Likely benign (Nov 01, 2023) | |||
4-82842275-G-A | not specified | Uncertain significance (Jun 28, 2024) | ||
4-82842330-G-GTA | Neurodevelopmental disorder with spastic quadriplegia, optic atrophy, seizures, and structural brain anomalies | Pathogenic (Nov 16, 2021) | ||
4-82842452-C-T | not specified | Uncertain significance (Aug 27, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SEC31A | protein_coding | protein_coding | ENST00000395310 | 26 | 82506 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000788 | 1.00 | 125528 | 1 | 218 | 125747 | 0.000871 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.23 | 559 | 647 | 0.864 | 0.0000320 | 7945 |
Missense in Polyphen | 127 | 177.4 | 0.71591 | 2240 | ||
Synonymous | -0.614 | 240 | 228 | 1.05 | 0.0000118 | 2390 |
Loss of Function | 5.35 | 21 | 68.9 | 0.305 | 0.00000363 | 775 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00955 | 0.00927 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000333 | 0.000308 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000329 | 0.0000327 |
Other | 0.00219 | 0.00179 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the coat protein complex II (COPII) which promotes the formation of transport vesicles from the endoplasmic reticulum (ER) (PubMed:10788476). The coat has two main functions, the physical deformation of the endoplasmic reticulum membrane into vesicles and the selection of cargo molecules (By similarity). {ECO:0000250|UniProtKB:Q9Z2Q1, ECO:0000269|PubMed:10788476}.;
- Disease
- DISEASE: Note=A chromosomal aberration involving SEC31A is associated with inflammatory myofibroblastic tumors (IMTs). Translocation t(2;4)(p23;q21) with ALK.;
- Pathway
- Protein processing in endoplasmic reticulum - Homo sapiens (human);Sterol Regulatory Element-Binding Proteins (SREBP) signalling;XBP1(S) activates chaperone genes;Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;MHC class II antigen presentation;Immune System;Adaptive Immune System;Class I MHC mediated antigen processing & presentation;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;COPII-mediated vesicle transport;ER to Golgi Anterograde Transport;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
(Consensus)
Recessive Scores
- pRec
- 0.136
Intolerance Scores
- loftool
- 0.787
- rvis_EVS
- -0.99
- rvis_percentile_EVS
- 8.63
Haploinsufficiency Scores
- pHI
- 0.390
- hipred
- N
- hipred_score
- 0.476
- ghis
- 0.581
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.913
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sec31a
- Phenotype
Zebrafish Information Network
- Gene name
- sec31a
- Affected structure
- endodermal cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- antigen processing and presentation of peptide antigen via MHC class I;intracellular protein transport;endoplasmic reticulum to Golgi vesicle-mediated transport;endoplasmic reticulum organization;antigen processing and presentation of exogenous peptide antigen via MHC class II;IRE1-mediated unfolded protein response;COPII vesicle coating;response to calcium ion;COPII-coated vesicle cargo loading;COPII-coated vesicle budding
- Cellular component
- Golgi membrane;cytoplasm;endoplasmic reticulum;endoplasmic reticulum membrane;cytosol;ER to Golgi transport vesicle membrane;vesicle coat;COPII vesicle coat;COPII-coated ER to Golgi transport vesicle;intracellular membrane-bounded organelle;perinuclear region of cytoplasm;endoplasmic reticulum exit site
- Molecular function
- structural molecule activity;protein binding;calcium-dependent protein binding